{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:52:21Z","timestamp":1786737141316,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Niger J Clin Pract"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/njcp.njcp_402_19","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T10:31:14Z","timestamp":1602498674000},"page":"1426","source":"Crossref","is-referenced-by-count":9,"title":["Total hip arthroplasty in sickle cell disease patients in a developing country"],"prefix":"10.4103","volume":"23","author":[{"given":"ME","family":"Ugbeye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Lawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Ayodabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EM","family":"Dim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Adegoke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1119-3077.297924-1","first-page":"37","volume-title":"Total hip arthroplasty in sickle cell disease","author":"Manzary","year":"2016","journal-title":"Reconstr Rev"},{"key":"key-10.4103\/1119-3077.297924-2","first-page":"447","volume-title":"Short term results of cementless total hip arthroplasty in sicklers","author":"Gulati","year":"2015","journal-title":"Indian J Orthop","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5413","issn-type":"print"},{"key":"key-10.4103\/1119-3077.297924-3","first-page":"11","volume-title":"Total hip arthroplasty in sickle-cell disease: Comparing cemented and non-cemented options","author":"Nikose","year":"2019","journal-title":"J Health Sci Res"},{"key":"key-10.4103\/1119-3077.297924-4","first-page":"492","volume-title":"Total hip replacement in sickle cell disorder: A preliminary report of challenges and early outcome of 21 consecutive patients","author":"Katchy","year":"2018","journal-title":"Nigerian J Clin Pract"},{"key":"key-10.4103\/1119-3077.297924-5","first-page":"157","volume-title":"Total hip replacement in sickle cell disease","author":"Al-Mousawi","year":"2002","journal-title":"Int Orthop"},{"key":"key-10.4103\/1119-3077.297924-6","first-page":"477","volume-title":"Non-cemented total hip arthroplasty in sickle-cell disease: Long-term results","author":"Ilyas","year":"2018","journal-title":"J Arthroplasty"},{"key":"key-10.4103\/1119-3077.297924-7","first-page":"730","volume-title":"Long term results with cementless Fitek (of Fitmore) cups","author":"Marchetti","year":"2005","journal-title":"J Arthroplasty"},{"key":"key-10.4103\/1119-3077.297924-8","first-page":"189","volume-title":"Is the Harris Hip Score system useful to study outcome of total hip replacement?","author":"Soderman","year":"2001","journal-title":"Clin Orthop Relat Res"},{"key":"key-10.4103\/1119-3077.297924-9","first-page":"e2018032","volume-title":"Perioperative management of sickle cell disease","author":"Adjepong","year":"2018","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"key-10.4103\/1119-3077.297924-10","first-page":"208","volume-title":"Total hip arthroplasty in sickle cell hemoglobinopathies","author":"Jeong","year":"2005","journal-title":"J Am Acad Orthop Surg"},{"key":"key-10.4103\/1119-3077.297924-11","first-page":"293","volume-title":"Total hip arthroplasty in osteonecrosis secondary to sickle cell disease","author":"Farook","year":"2019","journal-title":"Int Orthop"},{"key":"key-10.4103\/1119-3077.297924-12","first-page":"69","volume-title":"Complex primary total hip replacement in a patient with sickle cell disease and contralateral poliomyelitis: A case report and review of literature","author":"Ayekoloye","year":"2019","journal-title":"Nigerian J Orthop Trauma"},{"key":"key-10.4103\/1119-3077.297924-13","first-page":"1","volume-title":"Complications and failures of hip replacement in sickle cell disease","author":"Al-Mousawi","year":"2004","journal-title":"Bahrain Med Bull"},{"key":"key-10.4103\/1119-3077.297924-14","first-page":"853","volume-title":"Total hip arthroplasty in patients who have sickle cell heamoglobinopathy","author":"Bishop","year":"1988","journal-title":"J Bone Joint Surg"},{"key":"key-10.4103\/1119-3077.297924-15","first-page":"499","volume-title":"Osteonecrosis of the hip in the sickle-cell disease: Treatment and complications","author":"Hanker","year":"1988","journal-title":"J Bone Joint Surg"},{"key":"key-10.4103\/1119-3077.297924-16","doi-asserted-by":"crossref","unstructured":"Carden MA, Fay M, Sakurai Y, McFarland B, Blanche S, DiPrete C, et al. Normal saline is associated with increased sickle red cell stiffness and prolonged transit times in a microfluidic model of the capillary system. Microcirculation 2017;24. doi: 10.1111\/micc.12353.","DOI":"10.1111\/micc.12353"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:50:41Z","timestamp":1786733441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_402_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020]]}},"alternative-id":["297924"],"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_402_19","relation":{},"ISSN":["1119-3077"],"issn-type":[{"value":"1119-3077","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}